Skip to content
Acitretin
Soriatane (acitretin) is a small molecule pharmaceutical. Acitretin was first approved as Soriatane on 1996-10-28. It is used to treat psoriasis in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Acitretin
Tradename
Company
Number
Date
Products
SORIATANESTIEFEL LABS INCN-019821 DISCN1996-10-28
4 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
acitretinANDA2023-01-10
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
psoriasisEFO_0000676D011565L40
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D05: Antipsoriatics
— D05B: Antipsoriatics for systemic use
— D05BB: Retinoids for treatment of psoriasis
— D05BB02: Acitretin
HCPCS
No data
Clinical
Clinical Trials
3 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471C61—111—3
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameACITRETIN
INNacitretin
Description
All-trans-acitretin is an acitretin, a retinoid and an alpha,beta-unsaturated monocarboxylic acid. It has a role as a keratolytic drug.
Classification
Small molecule
Drug classretinol derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C
Identifiers
PDB—
CAS-ID55079-83-9
RxCUI16818
ChEMBL IDCHEMBL1131
ChEBI ID50173
PubChem CID5284513
DrugBankDB00459
UNII IDLCH760E9T7 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 3,922 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
65 adverse events reported
View more details